# Changzhou Qianhong Bio-pharma starts construction of $145M biologics plant in Changzhou

Changzhou Qianhong Bio-pharma has started construction of the second phase of its manufacturing plant in Changzhou National Hi-Tech District, investing ¥1 billion ($145 million). The facility will produce innovative biologic drugs, adding 200 million tablets and 60 million injections annually.

- Type: New facility
- Announced: 2018-12-05
- Where: Changzhou National Hi-Tech District, Changzhou, China
- Value: $145.0M
- Status: under construction
- Capacity: 200 million tablets and 60 million injections per year
- Products: biologic drugs, tablets, injections, molecular diagnosis reagents
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Changzhou Qianhong Bio-pharma](https://endata.com/companies/35922.md)

## Sources

- [fiercepharma.com](https://www.fiercepharma.com/manufacturing/chinese-api-maker-investing-145m-plant-view-to-producing-innovative-biologics-for), 2018-12-05: "Changzhou Qianhong Bio-pharma, Tuesday announced it has started construction of the ¥1 billion ($145 million) project in the Changzhou National Hi-Tech District."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.